You are herePharma News

Pharma News

USFDA allows marketing of the first newborn screening test to help detect Severe Combined Immunodeficiency

The U.S. Food and Drug Administration today allowed marketing of the EnLite Neonatal TREC Kit, the first screening test permitted to be marketed by FDA for Severe Combined Immunodeficiency (SCID) in newborns.

Scientists recognise Malaria parasites drug resistant

In two new studies, international research teams including NIAID scientists describe how certain genetic mutations make malaria-causing parasites resistant to artemisinin, a key drug for treating the disease. The findings are published in the Dec. 11, 2014, online issue of Science.

Ministry of Health and Family Welfare strengthening Drug Regulatory System in India

Department of Health and Family Welfare proposes to implement a Central Sector Scheme for Strengthening the Central Drugs Standard Control Organisation (CDSCO); and State Drug Regulatory System during the residual period of Twelfth Five Year Plan (2012 - 2017) at an estimated cost of Rs.900 crore and Rs.850 crore (excluding States’ share) respectively.

Tata Capital’s ‘India4India’ Survey Identifies Basic Healthcare and Illiteracy as the Top Challenges That India is Facing

(Business Wire India); Tata Capital, the financial services arm of the Tata Group, as part of its Do Right initiative, concluded a first-of-its-kind Survey to identify the major challenges facing our country today. The “Tata Capital India4India” Survey was conducted online on the website – & saw voting from more than 5000 respondents across the country. The top five challenges that emerged as the most concerning for the Indian public were Basic Healthcare, Illiteracy, Child Rights, Women Empowerment and Food Scarcity.

Addendum 2015 of the Indian Pharmacopoeia 2014 is published

IP Addendum-2015 to IP-2014 has been released on 28.11.2014 by Sh. Lov Verma, Secretary Health & Family Welfare and Chairman, India Pharmacopoeia Commission in the presence of senior officers of Ministry of Health & Family Welfare and Scientific Staff of IP Commission.

Naloxegol from Astrazeneca approved by EU

AstraZeneca announced that MOVENTIG® (naloxegol) has been granted Marketing Authorisation by the European Commission (EC) for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s). MOVENTIG is the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) to be approved in the European Union (EU).

Scientists found molecules that convert White fat to Brown / Good Fat

Harvard Stem Cell Institute (HSCI) researchers have taken what they describe as “the first step toward a pill that can replace the treadmill” for the control of obesity, though that shift, of course, would not provide all of the many benefits of exercise.

3D vaccines injection could fight cancer and HIV

One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences (SEAS) show a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.

Plastic can be degraded by gut bacteria from worms

Plastic is well-known for sticking around in the environment for years without breaking down, contributing significantly to litter and landfills. But scientists have now discovered that bacteria from the guts of a worm known to munch on food packaging can degrade polyethylene, the most common plastic. Reported in the ACS journal Environmental Science & Technology, the finding could lead to new ways to help get rid of the otherwise persistent waste, the scientists say.

GSK's Ebola Vaccine appears safe and shown encouraging immune response

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline (GSK), was tested at the NIH Clinical Center in Bethesda, Maryland. The interim results are reported online in advance of print in the New England Journal of Medicine.